MedTrace Logo

Analysis of the Sweat Response According to the Pathology in Neurologic Patients

NCT03639909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2018-08-21

No results posted yet for this study

Summary

Cardiovascular autonomic neuropathy (CAN) has been shown to be an important risk factor for cardiac diseases, particularly in diabetes.

CAN may be investigated by a battery of laboratory cardiovascular autonomic reflex tests(initially described by Ewing).

First screening for CAN (as proposed in diabetic patients) can be performed by assessing heart rate (HR) response to deep breathing, blood pressure (BP) and HR response to a 5 minutes stand test

Conditions

  • Neurological Disorder

Interventions

PROCEDURE

sweating function

Sweating dysfunction by Sudoscan

PROCEDURE

Cardiovascular function

Cardiovascular (CV) tests

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Anne Pavy-Le Traon, MD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-03-31
Completion
2017-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03639909 on ClinicalTrials.gov